Low gene expression of TNF, IL17A, IL23A, and IL12B in tumors: A safety surrogate to predict cancer survival associated with biologic therapies

J Am Acad Dermatol. 2021 Jul;85(1):249-252. doi: 10.1016/j.jaad.2020.08.050. Epub 2020 Aug 18.

¹ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Signature Healthcare Brockton Hospital, Department of Medicine, Brockton, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: jfmerola@bwh.harvard.edu.

No abstract available

Publication types